vs
ICU MEDICAL INC（ICUI）与Reddit, Inc.（RDDT）财务数据对比。点击上方公司名可切换其他公司
Reddit, Inc.的季度营收约是ICU MEDICAL INC的1.3倍（$725.6M vs $540.7M），Reddit, Inc.净利率更高（34.7% vs -2.9%，领先37.6%），Reddit, Inc.同比增速更快（69.7% vs -14.1%），Reddit, Inc.自由现金流更多（$263.6M vs $36.0M），过去两年Reddit, Inc.的营收复合增速更高（72.8% vs -2.3%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
Reddit是美国知名的社交新闻聚合与论坛类社交媒体平台，注册用户可发布链接、文字帖、图片、视频等各类内容，其他用户可对内容进行点赞或点踩，内容按主题归类到用户创建的子板块中，获赞更高的内容会排在板块前列，热度足够的内容还将展示在全站首页。
ICUI vs RDDT — 直观对比
营收规模更大
RDDT
是对方的1.3倍
$540.7M
营收增速更快
RDDT
高出83.8%
-14.1%
净利率更高
RDDT
高出37.6%
-2.9%
自由现金流更多
RDDT
多$227.7M
$36.0M
两年增速更快
RDDT
近两年复合增速
-2.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $725.6M |
| 净利润 | $-15.7M | $251.6M |
| 毛利率 | 37.5% | 91.9% |
| 营业利润率 | 1.0% | 31.9% |
| 净利率 | -2.9% | 34.7% |
| 营收同比 | -14.1% | 69.7% |
| 净利润同比 | 34.0% | 254.2% |
| 每股收益（稀释后） | $-0.63 | $1.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICUIRDDT
| Q4 25 | $540.7M | $725.6M | ||
| Q3 25 | $537.0M | $584.9M | ||
| Q2 25 | $548.9M | $499.6M | ||
| Q1 25 | $604.7M | $392.4M | ||
| Q4 24 | $629.8M | $427.7M | ||
| Q3 24 | $589.1M | $348.4M | ||
| Q2 24 | $596.5M | $281.2M | ||
| Q1 24 | $566.7M | $243.0M |
净利润ICUIRDDT
| Q4 25 | $-15.7M | $251.6M | ||
| Q3 25 | $-3.4M | $162.7M | ||
| Q2 25 | $35.3M | $89.3M | ||
| Q1 25 | $-15.5M | $26.2M | ||
| Q4 24 | $-23.8M | $71.0M | ||
| Q3 24 | $-33.0M | $29.9M | ||
| Q2 24 | $-21.4M | $-10.1M | ||
| Q1 24 | $-39.5M | $-575.1M |
毛利率ICUIRDDT
| Q4 25 | 37.5% | 91.9% | ||
| Q3 25 | 37.4% | 91.0% | ||
| Q2 25 | 37.9% | 90.8% | ||
| Q1 25 | 34.7% | 90.5% | ||
| Q4 24 | 36.1% | 92.6% | ||
| Q3 24 | 34.8% | 90.1% | ||
| Q2 24 | 34.8% | 89.5% | ||
| Q1 24 | 32.7% | 88.6% |
营业利润率ICUIRDDT
| Q4 25 | 1.0% | 31.9% | ||
| Q3 25 | 2.6% | 23.7% | ||
| Q2 25 | 1.9% | 13.6% | ||
| Q1 25 | 2.1% | 1.0% | ||
| Q4 24 | 6.0% | 12.4% | ||
| Q3 24 | 1.4% | 2.0% | ||
| Q2 24 | 1.3% | -11.0% | ||
| Q1 24 | -1.9% | -242.5% |
净利率ICUIRDDT
| Q4 25 | -2.9% | 34.7% | ||
| Q3 25 | -0.6% | 27.8% | ||
| Q2 25 | 6.4% | 17.9% | ||
| Q1 25 | -2.6% | 6.7% | ||
| Q4 24 | -3.8% | 16.6% | ||
| Q3 24 | -5.6% | 8.6% | ||
| Q2 24 | -3.6% | -3.6% | ||
| Q1 24 | -7.0% | -236.7% |
每股收益（稀释后）ICUIRDDT
| Q4 25 | $-0.63 | $1.24 | ||
| Q3 25 | $-0.14 | $0.80 | ||
| Q2 25 | $1.43 | $0.45 | ||
| Q1 25 | $-0.63 | $0.13 | ||
| Q4 24 | $-0.97 | $4.76 | ||
| Q3 24 | $-1.35 | $0.16 | ||
| Q2 24 | $-0.88 | $-0.06 | ||
| Q1 24 | $-1.63 | $-8.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $953.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.1B | $2.9B |
| 总资产 | $4.1B | $3.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ICUIRDDT
| Q4 25 | — | $953.6M | ||
| Q3 25 | — | $911.7M | ||
| Q2 25 | — | $734.1M | ||
| Q1 25 | — | $635.7M | ||
| Q4 24 | $308.6M | $562.1M | ||
| Q3 24 | $312.5M | $515.9M | ||
| Q2 24 | $302.6M | $468.0M | ||
| Q1 24 | $251.4M | $968.5M |
股东权益ICUIRDDT
| Q4 25 | $2.1B | $2.9B | ||
| Q3 25 | $2.1B | $2.6B | ||
| Q2 25 | $2.1B | $2.4B | ||
| Q1 25 | $2.0B | $2.2B | ||
| Q4 24 | $2.0B | $2.1B | ||
| Q3 24 | $2.0B | $2.0B | ||
| Q2 24 | $2.0B | $1.9B | ||
| Q1 24 | $2.1B | $1.8B |
总资产ICUIRDDT
| Q4 25 | $4.1B | $3.2B | ||
| Q3 25 | $4.1B | $2.9B | ||
| Q2 25 | $4.1B | $2.6B | ||
| Q1 25 | $4.2B | $2.4B | ||
| Q4 24 | $4.2B | $2.3B | ||
| Q3 24 | $4.3B | $2.2B | ||
| Q2 24 | $4.3B | $2.1B | ||
| Q1 24 | $4.3B | $2.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $266.8M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $263.6M |
| 自由现金流率自由现金流/营收 | 6.6% | 36.3% |
| 资本支出强度资本支出/营收 | 4.6% | 0.4% |
| 现金转化率经营现金流/净利润 | — | 1.06× |
| 过去12个月自由现金流最近4个季度 | $91.8M | $684.2M |
8季度趋势，按日历期对齐
经营现金流ICUIRDDT
| Q4 25 | $60.6M | $266.8M | ||
| Q3 25 | $56.7M | $185.2M | ||
| Q2 25 | $11.2M | $111.3M | ||
| Q1 25 | $51.3M | $127.6M | ||
| Q4 24 | $40.2M | $90.0M | ||
| Q3 24 | $36.1M | $71.6M | ||
| Q2 24 | $82.0M | $28.4M | ||
| Q1 24 | $45.8M | $32.1M |
自由现金流ICUIRDDT
| Q4 25 | $36.0M | $263.6M | ||
| Q3 25 | $27.6M | $183.1M | ||
| Q2 25 | $-8.5M | $110.8M | ||
| Q1 25 | $36.7M | $126.6M | ||
| Q4 24 | $16.1M | $89.2M | ||
| Q3 24 | $16.2M | $70.3M | ||
| Q2 24 | $62.5M | $27.2M | ||
| Q1 24 | $29.9M | $29.2M |
自由现金流率ICUIRDDT
| Q4 25 | 6.6% | 36.3% | ||
| Q3 25 | 5.1% | 31.3% | ||
| Q2 25 | -1.5% | 22.2% | ||
| Q1 25 | 6.1% | 32.3% | ||
| Q4 24 | 2.6% | 20.8% | ||
| Q3 24 | 2.7% | 20.2% | ||
| Q2 24 | 10.5% | 9.7% | ||
| Q1 24 | 5.3% | 12.0% |
资本支出强度ICUIRDDT
| Q4 25 | 4.6% | 0.4% | ||
| Q3 25 | 5.4% | 0.4% | ||
| Q2 25 | 3.6% | 0.1% | ||
| Q1 25 | 2.4% | 0.2% | ||
| Q4 24 | 3.8% | 0.2% | ||
| Q3 24 | 3.4% | 0.4% | ||
| Q2 24 | 3.3% | 0.4% | ||
| Q1 24 | 2.8% | 1.2% |
现金转化率ICUIRDDT
| Q4 25 | — | 1.06× | ||
| Q3 25 | — | 1.14× | ||
| Q2 25 | 0.32× | 1.25× | ||
| Q1 25 | — | 4.88× | ||
| Q4 24 | — | 1.27× | ||
| Q3 24 | — | 2.40× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
RDDT
| Advertising | $689.7M | 95% |
| Other Revenue | $35.9M | 5% |
